ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,197.67
0.68%
Dow Jones
38,814.37
0.09%
Gold vs US Dollar
2,324.165
0.16%
Brent Oil
84.275
0.45%
Bitcoin
64,419.95
-3.11%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kura Oncology Inc (KURA)

  7. Kura Oncology Inc (KURA) News

Kura Oncology (KURA)

Kura Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KURA
DateTimeSourceHeadlineSymbolCompany
07/06/202421:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KURAKura Oncology Inc
07/06/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KURAKura Oncology Inc
07/06/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KURAKura Oncology Inc
07/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KURAKura Oncology Inc
07/06/202412:30GlobeNewswire Inc.Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KURAKura Oncology Inc
29/05/202412:30GlobeNewswire Inc.Kura Oncology to Participate in Jefferies Global Healthcare ConferenceNASDAQ:KURAKura Oncology Inc
24/05/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KURAKura Oncology Inc
20/05/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KURAKura Oncology Inc
20/05/202421:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KURAKura Oncology Inc
14/05/202412:30GlobeNewswire Inc.Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AMLNASDAQ:KURAKura Oncology Inc
08/05/202412:30GlobeNewswire Inc.Kura Oncology to Participate in Bank of America Securities Healthcare ConferenceNASDAQ:KURAKura Oncology Inc
03/05/202412:30GlobeNewswire Inc.Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KURAKura Oncology Inc
02/05/202421:05GlobeNewswire Inc.Kura Oncology Reports First Quarter 2024 Financial ResultsNASDAQ:KURAKura Oncology Inc
25/04/202412:30GlobeNewswire Inc.Kura Oncology to Report First Quarter 2024 Financial ResultsNASDAQ:KURAKura Oncology Inc
22/04/202412:30GlobeNewswire Inc.Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AMLNASDAQ:KURAKura Oncology Inc
10/04/202412:30GlobeNewswire Inc.Kura Oncology to Participate in Stifel Targeted Oncology ForumNASDAQ:KURAKura Oncology Inc
05/04/202412:30GlobeNewswire Inc.Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KURAKura Oncology Inc
06/03/202412:30GlobeNewswire Inc.Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell CarcinomaNASDAQ:KURAKura Oncology Inc
01/03/202422:00GlobeNewswire Inc.Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KURAKura Oncology Inc
27/02/202421:52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KURAKura Oncology Inc
27/02/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KURAKura Oncology Inc
27/02/202421:01GlobeNewswire Inc.Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:KURAKura Oncology Inc
26/02/202412:30GlobeNewswire Inc.Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid LeukemiaNASDAQ:KURAKura Oncology Inc
22/02/202412:30GlobeNewswire Inc.Kura Oncology to Participate in Three Upcoming Investor ConferencesNASDAQ:KURAKura Oncology Inc
20/02/202412:30GlobeNewswire Inc.Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:KURAKura Oncology Inc
15/02/202421:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KURAKura Oncology Inc
15/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KURAKura Oncology Inc
14/02/202422:58Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KURAKura Oncology Inc
13/02/202422:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KURAKura Oncology Inc
09/02/202422:21Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KURAKura Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:KURA

Your Recent History

LSE
BIRD
Blackbird
LSE
SCE
Surface Transforms
LSE
THG
Thg
LSE
QBT
Quantum Blockchain Techn...
LSE
SOLG
Solgold
LSE
PANR
Pantheon Resources
LSE
GKP
Gulf Keystone Petroleum
LSE
AAZ
Anglo Asian Mining
LSE
GDR
Genedrive
LSE
JLP
Jubilee Metals
LSE
EEE
Empire Metals
LSE
CPX
Cap-xx
LSE
POS
Plexus
LSE
CHLL
Chill Brands
LSE
TERN
Tern
LSE
GGP
Greatland Gold
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved